Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 3, 2011, Pages 365-371

  Kodali, Dhatri ^a,c,d   Rawal, Ajay ^b   Ninan, Mary J ^a,c,d   Patel, Manish R ^a,c,d   Mesa, Hector ^b   Knapp, Dennis ^b   Schnitzer, Bertram ^e,f   Kratzke, Robert A ^c,d   Gupta, Pankaj ^a,c,g  

^a Hematology Oncology Section   (United States)

^b Department of Pathology ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Division of Hematology Oncology and Transplantation   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPPED RNA; EIF4EBP1 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

B CELL LYMPHOMA; CONFERENCE PAPER; FOLLICULAR LYMPHOMA; GENETICS; GERMINAL CENTER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOID TISSUE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PSEUDOLYMPHOMA; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; GERMINAL CENTER; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOID TISSUE; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; PHOSPHOPROTEINS; PHOSPHORYLATION; PSEUDOLYMPHOMA; RNA CAPS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952961510     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10(5):307-318.
2. Armengol G, Rojo F, Castellvi J, et al. 4E-binding protein 1 : a key molecular "funnel factor" in human cancer with clinical implications. Cancer Res. 2007; 67(16):7551-7555. (Pubitemid 47281345)
3. Thumma SC, Kratzke RA. Translational control: a target for cancer therapy. Cancer Lett. 2007;258(1):1-8. (Pubitemid 47600498)
4. Graff JR, Zimmer SG. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein elF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis. 2003;20(3):265-273. (Pubitemid 36513230)
5. Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM. Expression levels of elF4E, VEGF, and cyclin Dl, and correlation of elF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep. 2007;17(2):281-287.
6. Wendel HG, Silva RL, Malina A, et al. Dissecting elF4E action in tumorigenesis. Genes Dev. 2007;21(24):3232-3237.
7. Wendel HG, De Stanchina E, Fridman) S, et al. Survival signalling by Akt and elF4E in oncogenesis and cancer therapy. Nature. 2004;428(6980):332-337.
8. Graff JR, Konicek BW, Carter JH, Marcusson EG. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res. 2008;68(3):631-634. (Pubitemid 351206735)
9. Graff JR, Konicek BW, Lynch RL, et al. elF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res. 2009;69(9):3866-3873.
10. Graff JR, Konicek BW, Vincent TM, et al. Therapeutic suppression of translation initiation factor elF4E expression reduces tumor growth without toxicity. J Clin Invest. 2007;117(9):2638-2648. (Pubitemid 47494364)
11. Moerke NJ, Aktas H, Chen H, et al. Small-molecule inhibition of the interaction between the translation initiation factors elF4E and elF4G. Cell. 2007; 128(2):257-267. (Pubitemid 46137991)
12. Assouline S, Culjkovic B, Cocolakis E, et al. Molecular targeting of the oncogene elF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood. 2009;114(2):257-260.
13. Rizzieri DA, Feldman E, Dipersio JF, et al. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2008;14(9):2756-2762.
14. Bordeleau ME, Robert F, Gerard B, et al. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest. 2008;118(7):2651-2660. (Pubitemid 351949792)
15. Jacobson BA, Alter MD, Kratzke MG, et al. Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Res. 2006;66(8):4256-4262.
16. Jacobson BA, De A, Kratzke MG, et al. Activated 4E-BP1 represses tumourigenesis and IGF-1-mediated activation of the elF4F complex in mesothelioma. Br J Cancer. 2009;101(3):424-431.
17. Ruggero D, Montanaro L, Ma L, et al. The translation factor elF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004;10(5):484-486. (Pubitemid 38667906)
18. Wang S, Rosenwald IB, Hutzler MJ, et al. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol. 1999;155(1):247-255. (Pubitemid 29318722)
19. Zhao Y, Liu W, Zhou S, Zhou J, Sun H. Relationship between eukaryotic translation initiation factor 4E and malignant angiogenesis in non-Hodgkin lymphoma. J Huazhong Univ Sci Technol Med Sci. 2005;25(6):636-638.
20. Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol. 2006;169(6):2171-2180. (Pubitemid 351181976)
21. Kawamata N, Chen J, Koeffler HP. Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin Dl in mantle cell lymphoma cells. Blood. 2007;110(7):2667-2673. (Pubitemid 47523191)
22. Gingras AC, Raught B, Gygi SP, et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 2001;15(21):2852-2864. (Pubitemid 33042055)
23. Xu G, Zhang W, Bertram P, Zheng XF, McLeod H. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors. Int J Oncol. 2004;24(4):893-900.
24. El-Salem M, Raghunath PN, Marzec M, et al. Activation of mTORC1 signaling pathway in AIDS-related lymphomas. Am J Pathol. 2009;175(2):817-824.
25. Ninan M, Rawal A, Mesa H, Knapp D, Gupta P. Translation regulatory protein 4E-binding protein (BP)-1 phosphorylation identifies diffuse large B cell lymphoma patients with low IPI scores who experience short survival after chemotherapy [abstract 1925]. Blood. 2009;114(22):764.